Home › Bronchiolitis Obliterans Syndrome › California
Bronchiolitis Obliterans Syndrome clinical trials in California
15 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in California.
Cities in California
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
- Children's Hospital Los Angeles- Site Number : 8400009, Los Angeles
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Sep 22, 2026 · NCT07116031Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
- City of Hope, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT05996627A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- City of Hope Medical Center, Duarte
- Children'S Hospital Los Angeles Specialt, Los Angeles
- Lucile Packard Child Hospital End, Palo Alto
RecruitingPhase 2
Ages 2 to 17 · All sexes · Updated Sep 15, 2026 · NCT07124078A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- City of Hope Medical Center, Duarte
- University of California San Diego Medical Center, Moores Cancer Center, La Jolla
- University of Southern California, Los Angeles
- and 1 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT06585774Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- City of Hope, Duarte
- USC Norris Comprehensive Cancer Center, Los Angeles
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05919511Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
- University of California, San Francisco, San Francisco
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Jun 22, 2026 · NCT06663722A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- University of Southern California Norris Comprehensive Cancer Center, Los Angeles
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- Stanford University School of Medicine, Stanford
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT05922761A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Stanford Cancer Center, Palo Alto
- University of California San Francisco, San Francisco
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06615050LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
- University of California, San Francisco, San Francisco
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06018766Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
- Keck Medicine of USC, Los Angeles
- Hoag Hospital, Newport Beach
- Sutter Health, San Francisco
Recruiting
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT06464926A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury
- Rancho Research Institue, Downey
- University of California, San Diego, La Jolla
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Feb 12, 2026 · NCT06841770A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- City of Hope National Medical Center, Duarte
- Ronald Regan UCLA Medical Center, Los Angeles
- University of California Irvine Health, Orange
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- City of Hope, Duarte
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 15, 2025 · NCT06462365Freedom-1 Study for Chronic Knee Pain
- Western Clinical Research, Placentia
Recruiting
Ages 18 and older · All sexes · Updated Feb 13, 2025 · NCT03877653From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.